5 Healthcare Plays Powering the Sector’s Big Comeback

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

Should You Invest $1,000 in Pfizer Right Now?

Before you consider Pfizer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pfizer wasn't on the list.

While Pfizer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Ryan Hasson
About The Author

Ryan Hasson

Contributing Author

Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
UnitedHealth Group (UNH)
4.296 of 5 stars
$400.860.0%2.32%30.28Moderate Buy$409.75
Merck & Co., Inc. (MRK)
4.6338 of 5 stars
$114.040.1%2.98%32.12Moderate Buy$128.18
Eli Lilly and Company (LLY)
4.4325 of 5 stars
$1,098.780.0%0.63%39.03Moderate Buy$1,227.74
Health Care Select Sector SPDR Fund (XLV)N/A$149.40flat1.67%21.15Moderate Buy$149.40
Pfizer (PFE)
4.087 of 5 stars
$25.260.2%6.81%19.28Hold$28.82
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines